Erasca IncERAS
▼ ネガティブ規制関連度
Class action lawsuit alleges failure to disclose improper comparisons and patent/trade secret risks for ERAS-0015.
資産への影響 2
Biotech & Genomic Medicine
Erasca Inc
Revolution Medicines IncRVMD
± 混在競争関連度
Mentioned as the company whose data was improperly compared, but no direct impact on Revolution Medicines.